AP Biosciences Inc (TPEX:6945)
Taiwan
· Delayed Price · Currency is TWD 44.40
-0.30 (-0.67%)
Apr 24, 2025, 1:31 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 3.80 billion as of April 24, 2025. Its market cap has decreased by -3.87% in one year.
Market Cap
3.80B
Enterprise Value
2.14B
Revenue
32.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
44.40
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has decreased from 5.10B to 3.80B, a decrease of -25.36%. That is a compound annual growth rate of -15.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 3.80B | -10.04% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 165.85B |
| Caliway Biopharmaceuticals | 94.31B |
| Bora Pharmaceuticals Co., LTD. | 69.42B |
| Lotus Pharmaceutical | 56.52B |
| Oneness Biotech | 29.30B |
| Polaris Group | 29.08B |
| Lumosa Therapeutics | 26.77B |
| Pegavision | 25.55B |